Drugs / OCU400-301
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06388200 | Jun 2024 → Feb 2027 expected | retinitis pigmentosa | Ocugen | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OCU400-301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06388200 ↗ |
| Route | Other | “Sub-Retinal Administration of OCU400-301” NCT06388200 ↗ |